Area of research
Immunology · Hepatology
Research interest
Research interests include interferon and immune responses, Hepatitis C virus research, Immune Response and Inflammation, and Cytokine Signaling Pathways and Interactions.
A novel biosensor for the spatiotemporal analysis of STING activation during innate immune responses to dsDNA
Integrin beta 1 facilitates non-enveloped hepatitis E virus cell entry through the recycling endosome
The hepatitis E virus capsid protein ORF2 counteracts cell-intrinsic antiviral responses to enable persistent replication in cell culture
Time course and determinants of the antibody response to SARS-CoV-2 in Costa Rica: the RESPIRA study
Reconstitution of interferon regulatory factor 7 expression restores interferon beta induction in Huh7 cells
The hepatitis E virus capsid protein ORF2 counteracts cell-intrinsic antiviral responses to enable persistence in hepatocytes
RBM39 shapes innate immunity by controlling the expression of key factors of the interferon response
A population-based case–control study of COVID-19: methodological considerations on the role of testing bias
High-throughput screening of E3 ubiquitin ligases identifies TRIM48 as a novel negative regulator of RIG-I signaling
SARS-CoV-2 antibody and neutralization dynamics among persons with natural- and vaccine-induced exposures
Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals
Elevated Soluble ACE2 Activity in Children and Adults After SARS‐CoV‐2 Exposure Irrespective of Laboratory‐Confirmed Infection
Author Reply to Peer Reviews of RBM39 shapes innate immunity through transcriptional and splicing control of key factors of the interferon response
ADAR1-mediated RNA editing promotes B cell lymphomagenesis
Comparison of HAV and HCV infections in vivo and in vitro reveals distinct patterns of innate immune evasion and activation
Immune–epithelial cell cross‐talk enhances antiviral responsiveness to SARS‐CoV‐2 in children
High-resolution kinetic characterization of the RIG-I-signaling pathway and the antiviral response
Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategies
Cohort profile: evaluation of immune response and household transmission of SARS-CoV-2 in Costa Rica: the RESPIRA study
Tumour cells can escape antiproliferative pressure by interferon-β through immunoediting of interferon receptor expression
ADAR RNA editing on antisense RNAs results in apparent U-to-C base changes on overlapping sense transcripts
Estimating the cumulative incidence of SARS-CoV-2 infection in Costa Rica: modelling seroprevalence data in a population-based cohort
Cellular <scp>ROS</scp> tolerance determines the effect of plumbagin on osteoclast differentiation
Enhanced Airway Epithelial Response to SARS-CoV-2 Infection in Children is Critically Tuned by the Cross-Talk Between Immune and Epithelial Cells
RBM39 shapes innate immunity through transcriptional and splicing control of key factors of the interferon response
Influenza A virus strain PR/8/34, but neither HAM/2009 nor WSN/33, is transiently inhibited by the PB2-targeting drug paliperidone
SARS-CoV-2 infection induces a pro-inflammatory cytokine response through cGAS-STING and NF-κB
Effect of variants in LGP2 on MDA5-mediated activation of interferon response and suppression of hepatitis D virus replication
Cooperative effects of RIG-I-like receptor signaling and IRF1 on DNA damage-induced cell death
The Interferon Response Dampens the Usutu Virus Infection-Associated Increase in Glycolysis